Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCG2 | Q9UNQ0 | 3/20 | 0.78 |
| ▸ | MAOA | P21397 | 2/20 | 0.69 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.68 |
| ▸ | TNFRSF1A | P19438 | 2/20 | 0.64 |
| ▸ | CXCL12 | P48061 | 1/20 | 0.64 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.60 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.60 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.60 |
| ▸ | DPP4 | P27487 | 2/20 | 0.60 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.60 |
| ▸ | MAPT | P10636 | 2/20 | 0.59 |
| ▸ | P4HB | P07237 | 1/20 | 0.59 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.59 |
| ▸ | RAB9A | P51151 | 1/20 | 0.59 |
| ▸ | MEN1 | O00255 | 1/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.59 |
| ▸ | F3 | P13726 | 1/20 | 0.59 |
| ▸ | XDH | P47989 | 1/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.59 |
| ▸ | KRAS | P01116 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14837108 | 1.00 | ABCG2 (0.78) | ABCG2MAOACHRNA7TNFRSF1ACXCL12 | |
| SCHEMBL14836729 | 0.94 | ABCG2 (0.78) | ABCG2MAOACHRNA7TNFRSF1ACXCL12 | |
| SCHEMBL15155219 | 0.91 | ABCG2 (0.94) | ABCG2MAOATNFRSF1ACXCL12GABRA3 | |
| SCHEMBL15155210 | 0.91 | ABCG2 (0.94) | ABCG2MAOATNFRSF1ACXCL12GABRA3 | |
| SCHEMBL5606285 | 0.91 | ABCG2 (0.72) | ABCG2MAOACHRNA7TNFRSF1ACXCL12 | |
| SCHEMBL14837404 | 0.90 | ABCG2 (0.72) | ABCG2MAOACHRNA7MAPTRAB9A | |
| SCHEMBL28400854 | 0.90 | ABCG2 (0.72) | ABCG2MAOACHRNA7MAPTRAB9A | |
| SCHEMBL4160326 | 0.89 | ABCG2 (0.68) | ABCG2MAOACHRNA7DPP4MAPT | |
| SCHEMBL28695326 | 0.84 | CTSL (0.66) | ABCG2MAOACHRNA7DPP4PTPN1 | |
| SCHEMBL28695325 | 0.84 | CTSL (0.66) | ABCG2MAOACHRNA7DPP4PTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113956226-A | Method for synthesizing carvachin | 南京科技职业学院 | 2022-01-21 | — | — | CN | claimed |
| EP-1781305-A2 | COMPOSITIONS AND METHODS USING HYALURONIC ACID AND HYALURONIDASE INHIBITORS | ANGIOTECH INTERNATIONAL AG (CH) | 2007-05-09 | — | — | EP | claimed |
| WO-2006020994-A2 | COMPOSITIONS AND METHODS USING HYALURONIC ACID AND HYLURONIDASE INHIBITORS | ANGIOTECH INTERNATIONAL AG (CH) | 2006-02-23 | — | — | WO | claimed |
| CN-113956226-A | Method for synthesizing carvachin | 南京科技职业学院 | 2022-01-21 | — | — | CN | disclosed |
| EP-1781305-A2 | COMPOSITIONS AND METHODS USING HYALURONIC ACID AND HYALURONIDASE INHIBITORS | ANGIOTECH INTERNATIONAL AG (CH) | 2007-05-09 | — | — | EP | disclosed |
| US-20060040894-A1 | Compositions and methods using hyaluronic acid | ANGIOTECH INTERNATIONAL AG (CH) | 2006-02-23 | — | — | US | disclosed |
| WO-2006020994-A2 | COMPOSITIONS AND METHODS USING HYALURONIC ACID AND HYLURONIDASE INHIBITORS | ANGIOTECH INTERNATIONAL AG (CH) | 2006-02-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060040894-A1 | Compositions and methods using hyaluronic acid | CD44, MMP13, MMP1 | ABCG2 508/4885MAOA 554/4885CHRNA7 4283/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.